XM n’offre pas ses services aux résidents des États-Unis d’Amérique.

Growth is missing piece in UBS valuation puzzle



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BREAKINGVIEWS-Growth is missing piece in UBS valuation puzzle</title></head><body>

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

By Liam Proud

LONDON, Aug 14 (Reuters Breakingviews) -UBS UBSG.S boss Sergio Ermotti faces two big questions. Can he successfully integrate Credit Suisse, which his bank acquired last year in a state-backed rescue, and can he prove that the combined group has a reliable growth engine? Based on the bank’s most recent results, he’s convincing on the first point but less so on the second. That uncertainty will keep the $100 billion group’s valuation in check.

UBS is successfully shrinking the old Credit Suisse investment bank. The so-called non-core division should house just $48 billion of risk-weighted assets by the end of 2024, a 44% reduction from last summer’s level. The unit’s traders, under Beatriz Martin Jimenez, also appear to be exiting old Credit Suisse positions at a profit, since the division is also generating revenues.

Meanwhile, Ermotti is upping the pace of the integration. He added an extra $500 million to the cost cuts he plans to make this year, meaning that by the end of December he should be over halfway towards his overall 2026 savings target of $13 billion. The only quibble is how much of the benefit will drop down to UBS’s bottom line. Ermotti has so far failed to put a number on the proportion of savings he will use to fund investments.

The bigger question, though, is growth. The core wealth business and domestic Swiss bank both posted lower revenue in the second quarter of 2024 than in the first. Some of the factors may be temporary: rich clients are making fewer transactions, for example. And Ermotti can boast that the wealth unit saw $27 billion of net asset inflows in the second quarter – even as rival Morgan Stanley’s MS.N equivalent figure slumped.

Still, the growth rates for asset inflows in that key business are hardly inspiring at around 2% to 3% in recent quarters, partly because the division has been dumping less profitable clients. Ermotti wants to turbocharge things eventually, with a target of eventually grabbing $200 billion of net new assets a year by 2028. But it’s unclear exactly how he plans to do this. In any case, that goal is less than the equivalent inflow number that analysts are pencilling in for Morgan Stanley this year.

The gap arguably makes UBS’s valuation multiple of roughly 1 times forward tangible book value seem fair, even though wealth rivals like Morgan Stanley and Julius Baer BAER.S trade at 2 or 3 times, based on LSEG Datastream figures. For Ermotti, boosting the multiple means showing that he can also boost the top line.

Follow @Breakingviews on X


CONTEXT NEWS

UBS on Aug. 14 reported $11.1 billion of underlying revenue for the second quarter of 2024, up 10% year-on-year and down 7% compared with the first quarter. The bank’s underlying figures exclude integration-related one-offs from its acquisition of Credit Suisse in 2023.

The bank said that it expects to have cut $7 billion of costs because of the merger by the end of 2024, compared with a previous target of $6.5 billion.

It also increased the pace of its run-off of risk-weighted assets (RWAs) from the non-core and legacy unit, which is effectively the assets in the old Credit Suisse investment bank that UBS plans to either sell or let expire. RWAs will be $48 billion by the end of 2024 and $37 billion by the end of 2025, compared with previous targets of $56 billion and $45 billion, respectively.

Shares in UBS were up 2.35% to 25.71 Swiss francs as of 0750 GMT on Aug. 14.


UBS's uninspiring asset growth rate in the global wealth unit https://reut.rs/3M3PGEE


Editing by Aimee Donnellan and Streisand Neto

</body></html>

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques